Neurorestorative treatment of stroke: cell and pharmacological approaches.
about
Therapy Effects of Bone Marrow Stromal Cells on Ischemic StrokeCell based therapies for ischemic stroke: from basic science to bedsideMesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis.Casting doubt on the safety of "off-the-shelf" mesenchymal stem cells for cell therapy.Angiogenesis, neurogenesis and brain recovery of function following injuryNeurorestorative therapy for strokeThe beta-hCG+erythropoietin in acute stroke (BETAS) study: a 3-center, single-dose, open-label, noncontrolled, phase IIa safety trialSafety and Feasibility of Autologous Mesenchymal Stem Cell Transplantation in Chronic Stroke in Indian patients. A four-year follow upAutologous bone marrow mononuclear cells intrathecal transplantation in chronic strokeDevelopment of a middle cerebral artery occlusion model in the nonhuman primate and a safety study of i.v. infusion of human mesenchymal stem cells.HUCBCs increase angiopoietin 1 and induce neurorestorative effects after stroke in T1DM ratsNeuroprotective effects of Buyang Huanwu decoction on cerebral ischemia-induced neuronal damage.Mesenchymal stem cell therapy for acute radiation syndrome: innovative medical approaches in military medicineDose-dependent neurorestorative effects of delayed treatment of traumatic brain injury with recombinant human erythropoietin in ratsEffect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injuryPutative dental pulp-derived stem/stromal cells promote proliferation and differentiation of endogenous neural cells in the hippocampus of mice.Investigational agents for treatment of traumatic brain injuryTherapeutic effects of human umbilical cord blood-derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral ischemia.Herbal Formula Danggui-Shaoyao-San Promotes Neurogenesis and Angiogenesis in Rat Following Middle Cerebral Artery OcclusionIntraocular pressure reduction and neuroprotection conferred by bone marrow-derived mesenchymal stem cells in an animal model of glaucoma.Targeting caspase-6 and caspase-8 to promote neuronal survival following ischemic stroke.First-generation neuronal precursors in the crayfish brain are not self-renewing.RIGOR guidelines: escalating STAIR and STEPS for effective translational researchMagnetic resonance imaging investigation of axonal remodeling and angiogenesis after embolic stroke in sildenafil-treated ratsDelayed VEGF treatment enhances angiogenesis and recovery after neonatal focal rodent strokeNeuronal plasticity and functional recovery after ischemic stroke.Safety of epoietin beta-quinine drug combination in children with cerebral malaria in Mali.Delayed transplantation of human marrow stromal cell-seeded scaffolds increases transcallosal neural fiber length, angiogenesis, and hippocampal neuronal survival and improves functional outcome after traumatic brain injury in rats.Mechanisms and targets for angiogenic therapy after stroke.Effects of atorvastatin on plasma matrix metalloproteinase-9 concentration after glial tumor resection; a randomized, double blind, placebo controlled trial.Implications of vascular endothelial growth factor for postischemic neurovascular remodeling.Buyang Huanwu decoction increases angiopoietin-1 expression and promotes angiogenesis and functional outcome after focal cerebral ischemia.Human umbilical cord blood stem cells: rational for use as a neuroprotectant in ischemic brain disease.Molecular imaging for stem cell transplantation in neuroregenerative medicine.Experimental therapies for repair of the central nervous system: stem cells and tissue engineering.Progress in stem cell therapy for major human neurological disorders.The potential of mesenchymal stem cell in prion research.Effects of integrins and integrin αvβ3 inhibitor on angiogenesis in cerebral ischemic stroke.Phosphodiesterase inhibitors as therapeutics for traumatic brain injury.Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms.
P2860
Q26749052-D95C7386-2474-46E0-AAB5-34C9F9870739Q27025754-7ABD1062-96DB-400F-9506-C8CEA5A16A0DQ31133087-D30E0875-7C4D-414C-95B6-20E68D210EAFQ33713210-78098011-7279-45FF-B8F9-F42DAC1771EFQ33718009-E68F360E-385C-41E0-94DA-0F622D3A524AQ33813333-0D4BEDB8-B46E-4E5D-94B9-D790F8430D48Q33848061-14954C03-A6F5-4C37-90E6-77B7CB20D02CQ33863334-5DDCB8DE-D3D5-4205-8F18-67E6D981779CQ33999571-1597018B-3649-45A9-B8CF-3378700C94DBQ34062490-E441782E-7356-4DB5-9AFD-3CED57F3FD0FQ34270300-5CE15E3C-186E-4B2F-9297-C83DB249C57EQ34412794-2D74B312-C04F-45AD-A492-D39558C4410DQ35122122-0E0F8A05-715B-41E8-B25F-6B02127C9C1AQ35194540-D31EEE95-2789-465B-8392-23E0CB74E7F3Q35243800-6ED30A3B-4B1D-4D73-B91F-CD99CF6582DBQ35559758-D151C8B1-0E04-44D7-8256-5C24BCC1514BQ35611476-73F1BECA-5477-40D9-91C5-FE264DC62B27Q35840657-36162166-5755-4614-BE03-0DE0B1962007Q35871581-66E2338F-5CF0-4FFA-AED9-27D394375B40Q36071006-4556CB36-0E29-4EAC-8106-E58692A0ADBFQ36349902-F064E0B6-B91D-4084-8929-7AC069143074Q36746606-D1E54FC9-2860-43FF-B430-BFCDD56CD7A3Q36816551-8E01CEE6-F0D8-4115-9F7B-C6904A08DFC7Q36955444-810FA23B-224A-4F8D-9807-9D1BD3FC01E5Q37070545-56BE119F-F7AF-410E-8CCD-BE30C79E0C9BQ37077099-A0419C8A-6A3D-4272-83AC-BDA4883BE2D5Q37295436-0FA7C7DE-D6BA-404C-B474-AB7BBD1C3058Q37332690-706DD10E-CD4B-47CF-AEEA-E47CF61C9428Q37442498-9DB10344-3EEE-48CF-BA08-E0B204BDE855Q37496887-6C863F33-9461-4E68-9119-4021DC3DDB88Q37572370-1E0F1CE5-F9A1-4001-8DA5-235DAEE2C8A1Q37640402-AC43EB32-28CB-48BF-A696-CD1D236C40CFQ37801289-BECC063B-F150-47B3-AE72-A585E57BE5D2Q37951363-40E26B1F-7EAF-4DB0-88B7-12E2AF8648BDQ37998983-154B329C-A6BF-490A-B4E2-E9AF835C7D43Q38107439-0061E910-7823-4F85-94A1-936CC1988AB3Q38213991-9EA72DDA-2DE8-453A-A203-D4A3661B30BAQ38221073-78E41DA0-2120-4747-AD43-3574BEACABE4Q38243490-136D081A-89FD-44B4-A88E-A1C8B3B82E52Q39457984-51EA782B-4CF7-472C-9D03-E0797FA3AA71
P2860
Neurorestorative treatment of stroke: cell and pharmacological approaches.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Neurorestorative treatment of stroke: cell and pharmacological approaches.
@ast
Neurorestorative treatment of stroke: cell and pharmacological approaches.
@en
type
label
Neurorestorative treatment of stroke: cell and pharmacological approaches.
@ast
Neurorestorative treatment of stroke: cell and pharmacological approaches.
@en
prefLabel
Neurorestorative treatment of stroke: cell and pharmacological approaches.
@ast
Neurorestorative treatment of stroke: cell and pharmacological approaches.
@en
P2860
P1433
P1476
Neurorestorative treatment of stroke: cell and pharmacological approaches.
@en
P2093
Jieli Chen
P2860
P304
P356
10.1016/J.NURX.2006.07.007
P577
2006-10-01T00:00:00Z